Back to top
Quality System
Microsynth AG is certified to ISO 9001:2015 and accredited according to ISO/IEC 17025:2017 (STS 0429) for Sanger Sequencing, Next Generation Sequencing and Fragment length analysis. Microsynth's oligonucleotide synthesis facility is certified to EN ISO 13485:2016, which is a formal recognition of our competence for production and distribution of nucleic acids and components for medical use and provision of associated activities. The company participates in proficiency tests. Proficiency tests are an important part of on-going qualification/validation.
All our genetic analyses platforms are certified by Swissmedic as GMP-compliant for quality control (chemical, physical, biochemical and biological) of medicinal products as contract laboratory. The scope includes transplant products (TpP), gene therapy drugs (GT), as well as medicinal products involving genetically modified organisms (GMOs) or containing GMOs, all of them with intended use in humans.
The Qualified Person (QP) is in direct contact with relevant analytical coordinators on GxP issues and cooperates with the analytical departments to ensure continuous improvement. The QP provides details on corrective actions required for deviations and assists in the implementation of Quality Systems within all departments to ensure compliance with GxP. In addition, we are working according to the EU Guidelines for Good Manufacturing Practice (EudraLex - Volume 4 - Good Manufacturing Practice (GMP) guidelines / Arzneimittel-Bewilligungsverordnung, (AMBV)) and the ICH / PIC/S Guidance in GxP-projects (Contract Research).
Company structure in terms of processes, interfaces and responsibility of resources are described in the Quality Manual. Process performance is monitored via Key Performance Indicators (KPI) and continuously improved via quality objectives and continuous improvement (KV). QMS relevant documentation and the associated records are managed in a controlled manner. This includes approval and release, identification, creation date and versioning. Change management, a continuous improvement process and risk management are implemented. Non-conformities / OOS are linked to a CAPA process. Customer complaints and deviations are recorded and brought into team meetings for training.
Processes are described in procedures and SOPs. They are reviewed periodically. We maintain a clean and hygienic laboratory area. The processes are clearly defined, validated and controlled. Instruments are qualified. The requalification period is defined. Instrument related tests documents are archived. Changes that affect the quality are validated if necessary. In cases where the quality cannot be covered by verification, our processes are validated. Records demonstrate that all the steps required by the defined procedures and instructions are in fact taken. Deviations are investigated and documented. Records of testing that enable the complete history of a sample to be traced are retained in a comprehensible and accessible form.
Operators are trained regularly in practical work and documentation procedures. New personnel are trained according to an introductory plan. This is documented in a dedicated dossier. If new functions are taken over the pre-defined training/introduction must be attended.
Audits are performed to confirm that activities within the different processes correspond to internal and external demands, as well as to investigate the efficiency and suitability of the Quality Management System. By internal audits it is verified that the company policy is implemented throughout the entire organisation. Supplier qualification is performed regularly.
All our genetic analyses platforms are certified by Swissmedic as GMP-compliant for quality control (chemical, physical, biochemical and biological) of medicinal products as contract laboratory. The scope includes transplant products (TpP), gene therapy drugs (GT), as well as medicinal products involving genetically modified organisms (GMOs) or containing GMOs, all of them with intended use in humans.
The Qualified Person (QP) is in direct contact with relevant analytical coordinators on GxP issues and cooperates with the analytical departments to ensure continuous improvement. The QP provides details on corrective actions required for deviations and assists in the implementation of Quality Systems within all departments to ensure compliance with GxP. In addition, we are working according to the EU Guidelines for Good Manufacturing Practice (EudraLex - Volume 4 - Good Manufacturing Practice (GMP) guidelines / Arzneimittel-Bewilligungsverordnung, (AMBV)) and the ICH / PIC/S Guidance in GxP-projects (Contract Research).
Company structure in terms of processes, interfaces and responsibility of resources are described in the Quality Manual. Process performance is monitored via Key Performance Indicators (KPI) and continuously improved via quality objectives and continuous improvement (KV). QMS relevant documentation and the associated records are managed in a controlled manner. This includes approval and release, identification, creation date and versioning. Change management, a continuous improvement process and risk management are implemented. Non-conformities / OOS are linked to a CAPA process. Customer complaints and deviations are recorded and brought into team meetings for training.
Processes are described in procedures and SOPs. They are reviewed periodically. We maintain a clean and hygienic laboratory area. The processes are clearly defined, validated and controlled. Instruments are qualified. The requalification period is defined. Instrument related tests documents are archived. Changes that affect the quality are validated if necessary. In cases where the quality cannot be covered by verification, our processes are validated. Records demonstrate that all the steps required by the defined procedures and instructions are in fact taken. Deviations are investigated and documented. Records of testing that enable the complete history of a sample to be traced are retained in a comprehensible and accessible form.
Operators are trained regularly in practical work and documentation procedures. New personnel are trained according to an introductory plan. This is documented in a dedicated dossier. If new functions are taken over the pre-defined training/introduction must be attended.
Audits are performed to confirm that activities within the different processes correspond to internal and external demands, as well as to investigate the efficiency and suitability of the Quality Management System. By internal audits it is verified that the company policy is implemented throughout the entire organisation. Supplier qualification is performed regularly.